439 related articles for article (PubMed ID: 29922466)
1. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections.
Crowley EL; O'Toole A; Gooderham MJ
SAGE Open Med Case Rep; 2018; 6():2050313X18778723. PubMed ID: 29922466
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.
Genovese G; Caorsi R; Moltrasio C; Marzano AV
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():40-41. PubMed ID: 31535768
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.
Maronese CA; Moltrasio C; Marzano AV
Dermatol Clin; 2024 Apr; 42(2):247-265. PubMed ID: 38423685
[TBL] [Abstract][Full Text] [Related]
4. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
Vekic DA; Woods J; Lin P; Cains GD
Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
[TBL] [Abstract][Full Text] [Related]
5. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
De Souza A; Solomon GE; Strober BE
Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
[TBL] [Abstract][Full Text] [Related]
6. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
7. Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab).
Flora A; Holland R; Smith A; Frew JW
JAAD Case Rep; 2021 Aug; 14():33-36. PubMed ID: 34258349
[No Abstract] [Full Text] [Related]
8. SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab.
Yang Q; Xiang T; Wu Y; Ye E; He B; Bu Z
Clin Cosmet Investig Dermatol; 2022; 15():2547-2554. PubMed ID: 36466944
[TBL] [Abstract][Full Text] [Related]
9. SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.
Luzzati M; Simonini G; Filippeschi C; Giani T; Trapani S
Ital J Pediatr; 2020 Nov; 46(1):169. PubMed ID: 33187546
[TBL] [Abstract][Full Text] [Related]
10. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.
Magrey M; Khan MA
Curr Rheumatol Rep; 2009 Oct; 11(5):329-33. PubMed ID: 19772827
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report.
McKenzie SA; Ni CS; Hsiao JL
Cureus; 2019 Jun; 11(6):e4970. PubMed ID: 31453042
[TBL] [Abstract][Full Text] [Related]
12. Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial.
Wang L; Gong L; Zhang X; Cao Y; Long P; Zhang W; Zeng X; Li C
Clin Rheumatol; 2021 Jun; 40(6):2427-2438. PubMed ID: 33389313
[TBL] [Abstract][Full Text] [Related]
13. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome of femoral neoplasm-like onset: a case-based review.
Qiu C; Cheng L; Hou H; Liu T; Xu B; Xiao X; Wang Z; Wang Q
J Int Med Res; 2021 Dec; 49(12):3000605211065314. PubMed ID: 34932408
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis and paradoxical skin lesions by
Zhang X; Wu X; Li C
J Int Med Res; 2020 Sep; 48(9):300060520949100. PubMed ID: 32962502
[TBL] [Abstract][Full Text] [Related]
15. Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome Diagnosis in Adolescent and Isotretinoin as a Possible Serious Exacerbating Factor.
Shahada OO; Kurdi AS; Aljawi AF; Khayat LI; Shahadah AO
Cureus; 2022 Mar; 14(3):e22776. PubMed ID: 35371846
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a childhood synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with subcutaneous methotrexate: A case report.
Akçaboy M; Bakkaloğlu-Ezgü SA; Büyükkaragöz B; Isıyel E; Kandur Y; Hasanoğlu E; Buyan N
Turk J Pediatr; 2017; 59(2):184-188. PubMed ID: 29276872
[TBL] [Abstract][Full Text] [Related]
17. Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) Syndrome: Clinical and Therapeutic Aspects.
Condé K; Guelngar CO; Mohamed A; Adjibaye E; Cissé FA
Cureus; 2021 Sep; 13(9):e18332. PubMed ID: 34725595
[TBL] [Abstract][Full Text] [Related]
18. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a brief review of a rare condition.
Koh ET
Ann Acad Med Singap; 1998 Jan; 27(1):122-4. PubMed ID: 9588288
[TBL] [Abstract][Full Text] [Related]
19. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
[TBL] [Abstract][Full Text] [Related]
20. Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report.
Dierckx S; Nisolle JF; Boutsen Y
J Med Case Rep; 2024 Feb; 18(1):57. PubMed ID: 38360816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
